Amarin Corp PLC (AMRN) stock
AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3063% above fair value
$11.38−0.29 (-2.49%)
Close on Nov 13, 2026Market cap $251.55MP/E –Yield –
Amarin profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Amarin's profit margin for the twelve months ending Sep 30, 2026 was -10.9%. For fiscal 2025 it was -18.2%, against -35.9% the year before. The highest annual figure on record is 1.3% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -18.2% | +17.8 |
| FY2024 | Dec 31, 2024 | -35.9% | −16.7 |
| FY2023 | Dec 31, 2023 | -19.3% | +9.4 |
| FY2022 | Dec 31, 2022 | -28.7% | −30.0 |
| FY2021 | Dec 31, 2021 | 1.3% | +4.3 |
| FY2020 | Dec 31, 2020 | -2.9% | +2.3 |
| FY2019 | Dec 31, 2019 | -5.3% | +45.5 |
| FY2018 | Dec 31, 2018 | -50.8% | −13.3 |
| FY2017 | Dec 31, 2017 | -37.5% | +28.9 |
| FY2016 | Dec 31, 2016 | -66.4% | +74.5 |
| FY2015 | Dec 31, 2015 | -140.9% | −36.9 |
| FY2014 | Dec 31, 2014 | -104.0% | +526.8 |
| FY2013 | Dec 31, 2013 | -630.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 0.6% | +16.2 |
| Q2 FY2026 | Jun 30, 2026 | -18.1% | +1.3 |
| Q1 FY2026 | Mar 31, 2026 | -23.3% | +14.1 |
| Q4 FY2025 | Dec 31, 2025 | -2.5% | +75.5 |
| Q3 FY2025 | Sep 30, 2025 | -15.6% | +43.8 |
| Q2 FY2025 | Jun 30, 2025 | -19.4% | −21.7 |
| Q1 FY2025 | Mar 31, 2025 | -37.4% | −19.7 |
| Q4 FY2024 | Dec 31, 2024 | -78.0% | −70.3 |
| Q3 FY2024 | Sep 30, 2024 | -59.4% | −30.2 |
| Q2 FY2024 | Jun 30, 2024 | 2.3% | +24.2 |
| Q1 FY2024 | Mar 31, 2024 | -17.6% | +1.5 |
| Q4 FY2023 | Dec 31, 2023 | -7.7% | −8.7 |
| Q3 FY2023 | Sep 30, 2023 | -29.2% | −23.5 |
| Q2 FY2023 | Jun 30, 2023 | -21.9% | +52.2 |
| Q1 FY2023 | Mar 31, 2023 | -19.1% | +14.2 |
| Q4 FY2022 | Dec 31, 2022 | 0.9% | −9.2 |
| Q3 FY2022 | Sep 30, 2022 | -5.7% | +3.5 |
| Q2 FY2022 | Jun 30, 2022 | -74.1% | −79.1 |
| Q1 FY2022 | Mar 31, 2022 | -33.4% | −32.2 |
| Q4 FY2021 | Dec 31, 2021 | 10.2% | +7.2 |
| Q3 FY2021 | Sep 30, 2021 | -9.3% | −4.9 |
| Q2 FY2021 | Jun 30, 2021 | 5.1% | +1.8 |
| Q1 FY2021 | Mar 31, 2021 | -1.1% | +12.1 |
| Q4 FY2020 | Dec 31, 2020 | 2.9% | −2.0 |
| Q3 FY2020 | Sep 30, 2020 | -4.3% | −1.3 |
| Q2 FY2020 | Jun 30, 2020 | 3.3% | +5.1 |
| Q1 FY2020 | Mar 31, 2020 | -13.3% | +20.1 |
| Q4 FY2019 | Dec 31, 2019 | 4.9% | +48.5 |
| Q3 FY2019 | Sep 30, 2019 | -3.1% | +41.2 |
| Q2 FY2019 | Jun 30, 2019 | -1.8% | +63.2 |
| Q1 FY2019 | Mar 31, 2019 | -33.3% | +21.5 |
| Q4 FY2018 | Dec 31, 2018 | -43.5% | −1.8 |
| Q3 FY2018 | Sep 30, 2018 | -44.2% | −21.4 |
| Q2 FY2018 | Jun 30, 2018 | -65.0% | −34.8 |
| Q1 FY2018 | Mar 31, 2018 | -54.9% | +5.6 |
| Q4 FY2017 | Dec 31, 2017 | -41.7% | +29.2 |
| Q3 FY2017 | Sep 30, 2017 | -22.9% | – |
| Q2 FY2017 | Jun 30, 2017 | -30.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -60.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -70.9% | – |
See a number that looks wrong?